These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7211424)

  • 1. A new dosage schedule for pimozide in the acute stabilisation and maintenance treatment of psychosis.
    Noordhuizen GJ
    Acta Psychiatr Belg; 1980; 80(3):329-40. PubMed ID: 7211424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiences in the long term use of the 24 hour effective neuroleptic "pimozide" (Janssen)].
    König L; Lange E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():164-9. PubMed ID: 829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A series of multicentric pilot trials with pimozide in psychiatric practice. IV. Pimozide in the treatment of patients with paranoid symptomatology.
    Amery W; Boom AJ; Huisman NG; Kuipers H; van der Wiel HJ; Reyntjens A
    Acta Psychiatr Belg; 1972 Nov; 72(6):677-84. PubMed ID: 4679634
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
    Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
    Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
    [No Abstract]   [Full Text] [Related]  

  • 5. Acutely psychotic patients receiving high-dose haloperidol therapy.
    Remington G; Pollock B; Voineskos G; Reed K; Coulter K
    J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of pimozide.
    Anumonye A; Onibuwe-Johnson T; Marinho AA
    West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):17-24. PubMed ID: 799401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC; Lung FW; Chong MY
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pimozide as an adjuvant to maintenance therapy in chronic schizophrenia.
    Nakra BR; Wickramasinghe NA
    Pharmatherapeutica; 1980; 2(5):337-40. PubMed ID: 6107933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose-effect relations. Doubleblind study on two different doses of pimozide (author's transl)].
    Fleischhauer J
    Arzneimittelforschung; 1978; 28(9):1491-2. PubMed ID: 582541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with bromperidol in chronic psychoses].
    Bellomo LE; Rosset N; Tellarini L; Forconesi N
    Acta Psiquiatr Psicol Am Lat; 1988 Sep; 34(3):230-6. PubMed ID: 3071092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol: therapeutic window in schizophrenia.
    Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E
    J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pimozide (Orap) in patients with pseudo-neurotic behaviour.
    Tanghe AJ; Boom AJ; Leuridan P; Jonckheere L; Bruynooghe F
    Acta Psychiatr Belg; 1977; 77(2):294-305. PubMed ID: 906889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical observations on the use of primozide in the treatment of chronic schizophrenics.
    Frangos E
    Acta Psychiatr Belg; 1972 Nov; 72(6):698-707. PubMed ID: 4679652
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes.
    Andersen K; d'Elia G; Hållberg B; Perris C; Rapp W; Román G
    Acta Psychiatr Scand Suppl; 1974; 249():43-64. PubMed ID: 4608709
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.